Detalles de la búsqueda
1.
The discovery and evaluation of [18F]BMS-986229, a novel macrocyclic peptide PET radioligand for the measurement of PD-L1 expression and in-vivo PD-L1 target engagement.
Eur J Nucl Med Mol Imaging
; 51(4): 978-990, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38049658
2.
Evaluation of a PEGylated Fibroblast Growth Factor 21 Variant Using Novel Preclinical Magnetic Resonance Imaging and Magnetic Resonance Elastography in a Mouse Model of Nonalcoholic Steatohepatitis.
J Magn Reson Imaging
; 56(3): 712-724, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35092323
3.
Development, Characterization, and Radiation Dosimetry Studies of 18F-BMS-986229, a 18F-Labeled PD-L1 Macrocyclic Peptide PET Tracer.
Mol Imaging Biol
; 26(2): 301-309, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38123744
4.
Mapping the central effects of (±)-ketamine and traxoprodil using pharmacological magnetic resonance imaging in awake rats.
J Psychopharmacol
; 32(2): 146-155, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29378483
5.
Synthesis and Biologic Evaluation of a Novel 18F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression.
J Nucl Med
; 59(3): 529-535, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29025984
6.
A study of common discovery dosing formulation components and their potential for causing time-dependent matrix effects in high-performance liquid chromatography tandem mass spectrometry assays.
Rapid Commun Mass Spectrom
; 19(18): 2643-50, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16124030
Resultados
1 -
6
de 6
1
Próxima >
>>